Gender, age and dose effects of neonatally administered aspartate on the sexually dimorphic plasma growth hormone profiles regulating expression of the rat sex-dependent hepatic CYP isoforms

Drug Metabolism and Disposition

Volumn 25, Issue 11, 1997, Pages 1249-1256

  Agrawal, Arun K ^a   Shapiro, Bernard H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ETHOXYRESORUFIN DEETHYLASE; GROWTH HORMONE; OXYGENASE; PENTOXYRESORUFIN;

ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; PRIORITY JOURNAL; SEX DIFFERENCE;

AGING; ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID; BLOTTING, NORTHERN; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; ISOENZYMES; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 0030666215     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. J. W. Olney: Excitotoxic food additives: functional teratological aspects. Prog. Brain Res. 73, 283-294 (1988).
2. W. A. Reynolds, L. Parsons, and L. D. Stegink: Neuropathology studies following aspartame ingestion by infant nonhuman primates. In "Aspartame: Physiology and Biochemistry" (L. D. Stegink and L. J. Filer, Jr., eds.). pp. 363-378. Dekker, New York, 1984.
3. B. Bloch, N. Ling, R. Benoit, W. B. Wehrenherg, and R. Guillemin: Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature (Lond.) 307, 272-273 (1984).
4. B. H. Shapiro, J. N. MacLeod, N. A. Pampori, N. A. Morrissey, J. J. Lapenson, and D. J. Waxman: Signaling elements in the ultradian rhythm of growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 125, 2935-2944 (1989).
5. D. J. Waxman, J. J. Morrissey, J. N. MacLeod, and B. H. Shapiro: Depletion of serum growth hormone in adult female rats by neonatal monosodium glutamate treatment without loss of female-specific hepatic enzymes P450 2d (IIC12) and steroid 5α-reductase. Endocrinology 126, 712-720 (1990).
6. N. A. Pampori, A. K. Agrawal, D. J. Waxman, and B. H. Shapiro: Differential effects of neonatally administered glutamate on the ultradian pattern of circulating growth hormone regulating expression of sex-dependent forms of cytochrome P450. Biochem. Pharmacol. 41, 1299-1309 (1991).
7. C. Legraverend, A. Mode, T. Wells, I. Robinson, and J.-Å. Gustafsson: Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. Fed. Am. Soc. Exp. Biol. J. 6, 711-718 (1992).
8. D. J. Waxman: Modes of regulation of liver-specific steroid metabolizing cytochromes P450: Cholesterol 7α-hydroxylase, bile acid 6β-hydroxylase, and growth hormone-responsive steroid hormone hydroxylases. J. Steroid Biochem. Mol. Biol. 43, 1055-1072 (1992).
9. B. H. Shapiro, A. K. Agrawal, and N. A. Pampori: Gender differences in drug metabolism regulated by growth hormone. Int. J. Biochem. Cell Biol. 27, 9-20 (1995).
10. E. T. Morgan, C. MacGoech, and J.-A. Gustafsson: Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16α-hydroxylase cytochrome P450 apoprotein in the rat. J. Biol. Chem. 260, 11895-11898 (1985).
11. B. Schainker, and J. W. Olney: Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy. J. Neural Transm. 35, 207-215 (1974).
12. A. K. Agrawal, N. A. Pampori, and B. H. Shapiro: Sex-and dose-dependent effects of neonatally administered aspartate on the ultradian patterns of circulating growth hormone regulating hexobarbital metabolism and action. Toxicol. Appl. Pharmacol. 108, 96-106 (1991).
13. D. E. Ryan and W. Levin: Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther.: 45, 153-239 (1990).
14. N. A. Pampori, A. K. Agrawal, and B. H. Shapiro: Renaturalizing the sexually dimorphic profile of circulating growth hormone in hypophysectomized rats. Acta Endocrinol. 124, 283-289 (1991).
15. N. A. Pampori, M. K. Pampori, and B. H. Shapiro: Dilution of the chemiluminescence reagents reduces the background noise on Western blots. BioTechniques 18, 588-590 (1995).
16. N. A. Pampori and B. H. Shapiro: Feminization of hepatic P450s by nominal levels of growth hormone in the feminine plasma profile. Mol. Pharmacol. 50, 1148-1156 (1996).
17. P. Chomczynski and N. Sacchi: Single step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
18. D. J. Waxman: Rat hepatic P450IIA and P450IIC subfamily expression using catalytic, immunochemical and molecular probes. Methods Enzymol. 206, 249-267 (1991).
19. P. A. Ram and D. J. Waxman: Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Mol. Endocrinol. 5, 13-20 (1991).
20. N. A. Pampori and B. H. Shapiro: Over-expression of CYP2C11 in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate. J. Pharmacol. Exp. Ther. 271, 1067-1073 (1994).
21. C. J. Omiecinski, F. G. Walz, Jr., and G. P. Vlasuk: Phenobarbital induction of rat liver cytochrome P-450b and P-450e. Quantitation of specific RNAs by hybridization to synthetic oligodeoxyribonucleotide probes. J. Biol. Chem. 260, 3247-3250 (1985).
22. E. G. Schuetz, J. D. Schuetz, B. May, and P. S. Guzelian: Regulation of cytochrome P-450b/e and P-450p gene expression by growth hormone in adult rat hepatocytes cultured on a reconstituted basement membrane. J. Biol. Chem. 265, 1188-1192 (1990).
23. R. Ramsden, K. M. Sommer, and C. J. Omiecinski: Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J. Biol. Chem. 268, 21722-21726 (1993).
24. J. B. Schenkman: Steroid metabolism by constitutive cytochromes P450. J. Steroid Biochem. Mol. Biol. 43, 1023-1030 (1992).
25. N. A. Pampori and B. H. Shapiro: Effects of neonatally administered monosodium glutamate on the sexually dimorphic profiles of circulating growth hormone regulating murine hepatic monooxygenases. Biochem. Pharmacol. 47, 1221-1229 (1994).
26. A. K. Agrawal, N. A. Pampori, and B. H. Shapiro: Thin-layer chromatographic separation of regioselective and stereospecific androgen metabolites. Anal. Biochem. 224, 455-457 (1995).
27. M. D. Burke and R. T. Mayer: Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2, 583-588 (1974).
28. D. R. Dutton and A. Parkinson: Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. Arch. Biochem. Biophys. 268, 617-629 (1989).
29. A. Aitio: A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal. Biochem. 85, 488-491 (1978).
30. H. W. Strobel and J. D. Dignam: Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol. 52, 89-96 (1978).
31. P. A. Ram and D. J. Waxman: Pretranslational control by thyroid hormone of rat liver steroid 5α-reductase and comparison to the thyroid dependence of two growth hormone-regulated CYP2C mRNAs. J. Biol. Chem. 265, 19223-19229 (1990).
32. A. K. Agrawal and B. H. Shapiro: Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Mol. Pharmacol. 49, 523-531 (1996).
33. T. Nakajima, E. Elovaara, S. S. Park, H. V. Gelboin, E. Hietanen, and H. Vainio: Monoclonal antibody directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes. Biochem. Pharmacol. 40, 1255-1261 (1990).
34. M. A. Alterman, M. J. Carvan, and D. L. Busbee: Ethoxyresorufin and pentoxyresorufin O-dealkylation by hepatic microsomes from female Fischer 344 rats: effects of age and diet. Mech. Aging Develop. 77, 1-11 (1994).
35. H. Yamazaki, M. Mimura, C. Sugahara, and T. Shimada: Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7α-and coumarin 7-hydroxylations. Biochem. Pharmacol. 48, 1524-1527 (1994).
36. Y. Yamazoe, X. Ling, N. Murayama, D. Gong, K. Nagata, and R. Kato: Modulation of hepatic level of microsomal testosterone 7αhydroxylase, P-450a (P450IIA1), by thyroid hormone and growth hormone in rat liver. J. Biochem (Tokyo) 108, 599-603 (1990).
37. D. J. Waxman, G. A. LeBlanc, J. J. Morrissey, J. Staunton, and D. P. Lapenson: Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression. J. Biol. Chem. 263, 11396-11406 (1988).
38. D. J. Waxman, P. A. Ram, N. A. Pampori, and B. H. Shapiro: Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: Induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol. Pharmacol. 48, 790-797 (1995).
39. N. A. Pampori and B. H. Shapiro: Subnormal concentrations in the feminine profile of circulating growth hormone enhance expression of female-specific CYP2C12. Biochem. Pharmacol. 47, 1999-2004 (1994).
40. D. J. Waxman, N. A. Pampori, P. A. Ram, A. K. Agrawal, and B. H. Shapiro: Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic P450. Proc. Natl. Acad. Sci. USA 88, 6868-6872 (1991).
41. B. H. Shapiro, R. C. Albucher, J. N. MacLeod, and M. S. Bitar: Normal levels of hepatic drug-metabolizing enzymes in neonatally induced, growth hormone deficient adult male and female rats. Drug Metab. Dispos. 14, 585-589 (1986).
42. M. Ono, N. Miki, and H. Demura: Effect of antiserum to rat growth hormone (GH)-releasing factor on physiological GH secretion in female rats. Endocrinology 129, 1791-1796 (1991).